In accord with the importance of TGF-β in the myeloid cell autophagic systems, the treatment with TGF-βR-KI suppressed the tumor invasive activities mediated by tumor-infiltrating myeloid cells to levels similar to those of cells undergoing autophagy inhibition (Fig 8D). This evidence concerns the gene TGFB1 and neoplasm.